Error message

  • Notice: Undefined index: parallax_zymphonies_theme in drupal_theme_initialize() (line 100 of /home/therapurebio/html/biologics/includes/theme.inc).
  • Notice: Trying to get property of non-object in _drupal_theme_initialize() (line 146 of /home/therapurebio/html/biologics/includes/theme.inc).
  • Notice: Trying to get property of non-object in _theme_load_registry() (line 335 of /home/therapurebio/html/biologics/includes/theme.inc).
  • Notice: Undefined index: parallax_zymphonies_theme in theme_get_setting() (line 1439 of /home/therapurebio/html/biologics/includes/theme.inc).

About Us

About Us

Therapure Biologics focuses on the development of a portfolio of its own plasma-derived pharmaceutical products using its proprietary technology, PlasmaCap EBA™ and building on Therapure Biopharma’s biomanufacturing capabilities and plasma protein expertise.

Our work today is concentrated on three important plasma proteins: intravenous immunoglobulin (IVIG), albumin, and alpha-1 antitrypsin (AAT) which are established products in the plasma protein industry with growing demand. Using our extensive knowledge in plasma proteins and working with key industry players, we have developed a program to launch these products to address the needs of the market.

A Canadian-based company, Therapure Biologics is committed to driving advancements in plasma’s potential both locally and around the world.

Learn more about our pipeline of plasma proteins.

Value Proposition

You could say that plasma protein therapeutics are in our blood. Therapure Biologics, a division of Therapure Biopharma, is bringing forward new and exciting advancements in the plasma protein marketplace. Our unique technology represents the first transformative manufacturing innovation in the industry in over 70 years and our mission is to provide physicians and their patients with new, high-quality, dependable therapeutic solutions. A Canadian-based company, Therapure Biologics is committed to driving advancements in plasma’s potential both locally and around the world.

Learn more about our plasma proteins by visiting our Pipeline section.

Elegant Technology

Central to our business is an advanced plasma protein manufacturing technology called PlasmaCap EBA™. We developed and invested in the underlying technology and have optimized it for use with plasma.

All other commercial manufacturers currently serving the North American market extract plasma proteins using a process called “fractionation” that was originally developed in the 1940s and includes a cold alcohol step. Our PlasmaCap EBA™ is an elegant technology that allows the sequential isolation of multiple proteins from plasma.

To learn more about how plasma protein manufacturers and other biomanufacturing organizations can take advantage of PlasmaCap EBA™, please contact us.

We are committed to supporting patient needs by providing a reliable and consistent supply of plasma products. This can be accomplished with our higher production yields which result in increased availability and access for our growing network of partners.

Manufacturing strength and values

Therapure Biologics benefits from the strong history in process development and CGMP biomanufacturing within Therapure Biopharma Inc. Our flexible, state-of-the-art facility is supported by robust quality control and quality assurance programs, and our development, manufacturing and support groups have worked together to manufacture numerous biologic products for clients.

As it does in all Therapure divisions, our absolute commitment to quality and patient safety underpins all we do.

Our Mission

Patients depend on plasma protein therapeutics. They are used in emergency care and to treat life-threatening, usually chronic, diseases. Our mission at Therapure Biologics is to produce a reliable supply of safe and effective plasma protein therapeutics by using new technologies to optimize their production.

Learn more about our pipeline of plasma proteins.